Histone Methyltransferases as Novel Drug Targets

Epigenetic Targets in Drug Discovery

Volumn 42, Issue , 2010, Pages 251-268

  Jung, Manfred ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Arginine methyltransferase; Epigenetics; Histone methyltransferases; Lysine methyltransferase; PRMT

Indexed keywords

EID: 85008215422     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527627073.ch12     Document Type: Chapter

References (95)

1. Schäfer, S. and Jung, M. (2005) Chromatin modifications as targets for new anticancer drugs. ArchivesofPharmarcy Chemistry and Life Sciences, 338, 347-357.
2. Biel, M., Wascholowski, V. and Giannis, A. (2005) Epigenetics-An epicenter of gene regulation: Histones and histonemodifying enzymes. Angewandte Chemie (International Edition in English), 44, 3186-3216.
3. Yang, X.J. and Seto, E. (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene, 26, 5310-5318.
4. Minucci, S. and Pelicci, P.G. (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nature Reviews. Cancer, 6, 38-51.
5. Herranz, M. and Esteller, M. (2006) New therapeutic targets in cancer: the epigenetic connection. Clinical Transplants and Oncology, 8, 242-249.
6. Paris, M., Porcelloni, M., Binaschi, M. and Fattori, D. (2008) Histone deacetylase inhibitors: from bench to clinic. Journal of Medicinal Chemistry, 51, 1505-1529.
7. Spannhoff,A., Sippl,W.and Jung, M. (2008) Cancer treatment of the future: inhibitors of histone methyltransferases. The International Journal ofBiochemistry & Cell Biology, 10.1016/j.biocel.2008.1007.1024.
8. Rice, J.C. and Allis, C.D. (2001) Histone methylation versus histone acetylation: new insights into epigenetic regulation. Current Opinion in Cell Biology, 13, 263-273.
9. Kouzarides, T. (2002) Histone methylation in transcriptional control. Current Opinion in Genetics & Development, 12, 198-209.
10. Trievel, R.C. (2004) Structure and function of histone methyltransferases. Critical Reviews in Eukaryotic Gene Expression, 14, 147-169.
11. Qian, C. and Zhou, M.M. (2006) SET domain protein lysine methyltransferases: Structure, specificityandcatalysis. Cellular and Molecular Life Sciences, 63, 2755-2763.
12. Morgunkova, A. and Barlev, N.A. (2006) Lysine methylation goes global. Cell Cycle (Georgetown, Tex), 5, 1308-1312.
13. Rathert, P., Dhayalan, A., Murakami, M., Zhang, X., Tamas, R., Jurkowska, R., Komatsu, Y., Shinkai, Y, Cheng, X. and Jeltsch, A. (2008) Protein lysine methyltransferase G9a acts on non-histone targets. Nature Chemical Biology, 4, 344-346.
14. Kouzarides, T. (2007) Chromatin modifications and their function. Cell, 128, 693-705.
15. Bedford, M.T. and Richard, S. (2005) Arginine methylation an emerging regulator of protein function. Molecular Cell, 18, 263-272.
16. Bedford, M.T. (2007) Arginine methylation at a glance. Journal of Cell Science, 120, 4243-4246.
17. Cheng, D., Cote, J., Shaaban, S. and Bedford, M.T. (2007) The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Molecular Cell, 25, 71-83.
18. Pahlich, S., Bschir, K., Chiavi, C., Belyanskaya, L. and Gehring, H. (2005) Different methylation characteristics of protein arginine methyltransferase 1 and 3 toward the Ewing Sarcoma protein and a peptide. Proteins, 61, 164-175.
19. Chevillard-Briet, M., Trouche, D. and Vandel, L. (2002) Control of CBP coactivating activity by arginine methylation. The EMBO Journal, 21, 5457-5466.
20. Brahms, H., Meheus, L., de Brabandere, V., Fischer, U. and Luhrmann, R. (2001) Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B0 and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA (New York, NY), 7, 1531-1542.
21. Dery, U., Coulombe, Y., Rodrigue, A., Stasiak, A., Richard, S. and Masson, J.Y. (2008) A glycine-arginine domain in control of the human MRE11 DNA repair protein. Molecular and Cellular Biology, 28, 3058-3069.
22. Boisvert, F.M., Dery, U., Masson, J.Y. and Richard, S. (2005) Arginine methylation ofMRE11 by PRMT1 is required for DNA damage checkpoint control. Genes and Development, 19, 671-676.
23. Pahlich, S., Zakaryan, R.P. and Gehring, H. (2006) Protein arginine methylation: Cellular functions and methods of analysis. Biochimica et Biophysica Acta, 1764, 1890-1903.
24. Cote, J. and Richard, S. (2005) Tudor domains bind symmetrical dimethylated arginines. The Journal of Biological Chemistry, 280, 28476-28483.
25. Lin, W.J., Gary, J.D., Yang, M.C., Clarke, S. and Herschman, H.R. (1996) The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. The Journal of Biological Chemistry, 271, 15034-15044.
26. Robin-Lespinasse, Y., Sentis, S., Kolytcheff, C., Rostan, M.C., Corbo, L. and Le Romancer, M. (2007) hCAF1, a new regulator of PRMT1-dependent arginine methylation. Journal of Cell Science, 120, 638-647.
27. Higashimoto, K., Kuhn, P., Desai, D., Cheng, X. and Xu, W. (2007) Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1. Proceedings of the National Academy of Sciences of the United States ofAmerica, 104, 12318-12323.
28. Ruthenburg, A.J., Li, H., Patel, D.J. and Allis, C.D. (2007) Multivalent engagement of chromatin modifications by linked binding modules. Nature Reviews. Molecular Cell Biology, 8, 983-994.
29. Shogren-Knaak, M.A. and Peterson, C.L. (2004) Creating designer histones by native chemical ligation. Methods in Enzymology, 375, 62-76.
30. Shogren-Knaak, M.A., Fry, C.J. and Peterson, C.L. (2003) A native peptide ligation strategy for deciphering nucleosomal histone modifications. The Journal ofBiological Chemistry, 278, 15744-15748.
31. Simon, M.D., Chu, F., Racki, L.R., de la Cruz, C.C., Burlingame, A.L., Panning, B., Narlikar, G.J. and Shokat, K.M. (2007) The site-specific installation of methyl-lysine analogs into recombinant histones. Cell, 128, 1003-1012.
32. Jenuwein, T. and Allis, C.D. (2001) Translating the histone code. Science, 293, 1074-1080.
33. Chuikov, S., Kurash, J.K., Wilson, J.R., Xiao, B., Justin, N., Ivanov, G.S., McKinney, K., Tempst, P., Prives, C., Gamblin, S.J., Barlev, N.A. and Reinberg, D. (2004) Regulation of p53 activity through lysine methylation. Nature, 432, 353-360.
34. Huang, J., Sengupta, R., Espejo, A.B., Lee, M.G., Dorsey, J.A., Richter, M., Opravil, S., Shiekhattar, R., Bedford, M.T., Jenuwein, T. and Berger, S.L. (2007) p53 is regulated by the lysine demethylase LSD1. Nature, 449, 105-108.
35. Shi, X., Kachirskaia, I., Yamaguchi, H., West, L.E., Wen, H., Wang, E.W., Dutta, S., Appella, E. and Gozani, O. (2007) Modulation of p53 function by SET8-mediated methylation at lysine 382. Molecular Cell, 27, 636-646.
36. Huang, J. and Berger, S.L. (2008) The emerging field of dynamic lysine methylation of non-histone proteins. Current Opinion in Genetics & Development, 18, 152-158.
37. Van Duyne, R., Easley, R., Wu, W., Berro, R., Pedati, C., Klase, Z., Kehn-Hall, K., Flynn, E.K., Symer, D.E. and Kashanchi, F. (2008) Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. Retrovirology, 5, 40.
38. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J.R., Cole, P.A. and Casero, R.A. (2004) Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1. Cell, 119, 941-953.
39. Metzger, E., Wissmann, M., Yin, N., Muller, J.M., Schneider, R., Peters, A.H., Gunther, T., Buettner, R. and Schule, R. (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature, 437, 436-439.
40. Agger, K., Christensen, J., Cloos, P.A. and Helin, K. (2008) The emerging functions of histone demethylases. Current Opinion in Genetics & Development, 18, 1-10.
41. Tsukada, Y., Fang, J., Erdjument-Bromage, H., Warren, M.E., Borchers, C.H., Tempst, P. and Zhang, Y. (2006) Histone demethylation by a family ofJmjC domain-containing proteins. Nature, 439, 811-816.
42. Cloos, P.A., Christensen, J., Agger, K., Maiolica, A., Rappsilber, J., Antal, T., Hansen, K.H. and Helin, K. (2006) The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature, 442, 307-311.
43. Wissmann, M., Yin, N., Muller, J.M., Greschik, H., Fodor, B.D., Jenuwein, T., Vogler, C., Schneider, R., Gunther, T., Buettner, R., Metzger, E. and Schule, R. (2007) Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nature Cell Biology, 9, 347-353.
44. Chang, B., Chen, Y., Zhao, Y. and Bruick, R.K. (2007) JMJD6 is a histone arginine demethylase. Science, 318, 444-447.
45. Cuthbert, G.L., Daujat, S., Snowden, A.W., Erdjument-Bromage, H., Hagiwara, T., Yamada, M., Schneider, R., Gregory, P.D., Tempst, P., Bannister, A.J. and Kouzarides, T. (2004) Histone deimination antagonizes arginine methylation. Cell, 118, 545-553.
46. Krause, C.D., Yang, Z.H., Kim, Y.S., Lee, J.H., Cook, J.R. and Pestka, S. (2007) Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacology & Therapeutics, 113, 50-87.
47. Allis, C.D., Berger, S.L., Cote, J., Dent, S., Jenuwein, T., Kouzarides, T., Pillus, L., Reinberg, D., Shi, Y., Shiekhattar, R., Shilatifard, A., Workman, J. and Zhang, Y. (2007) New nomenclature for chromatinmodifying enzymes. Cell, 131, 633-636.
48. Miranda, T.B., Miranda, M., Frankel, A. and Clarke, S. (2004) PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specificity. The Journal of Biological Chemistry, 279, 22902-22907.
49. Lee, J.H., Cook, J.R., Yang, Z.H., Mirochnitchenko, O., Gunderson, S.I., Felix, A.M., Herth, N., Hoffmann, R. and Pestka, S. (2005) PRMT7, a new protein arginine methyltransferase that synthesizes symmetric dimethylarginine. The Journal of Biological Chemistry, 280, 3656-3664.
50. Tang, J., Frankel, A., Cook, R.J., Kim, S., Paik, W.K., Williams, K.R., Clarke, S. and Herschman, H.R. (2000) PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. The Journal ofBiological Chemistry, 275, 7723-7730.
51. Koh, S.S., Chen, D., Lee, Y.H. and Stallcup, M.R. (2001) Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. The Journal of Biological Chemistry, 276, 1089-1098.
52. Koh, S.S., Li, H., Lee, Y.H., Widelitz, R.B., Chuong, C.M. and Stallcup, M.R. (2002) Synergistic coactivator function by coactivator-associated arginine methyltransferase (CARM) 1 and beta-catenin with two different classes of DNA-binding transcriptional activators. The Journal ofBiological Chemistry, 277, 26031-26035.
53. Cheng, D., Yadav, N., King, R.W., Swanson, M.S., Weinstein, E.J. and Bedford, M.T. (2004) Small molecule regulators of protein arginine methyltransferases. The Journal of Biological Chemistry, 279, 23892-23899.
54. Spannhoff, A., Heinke, R., Bauer, I., Trojer, P., Metzger, E., Gust, R., Schüle, R., Brosch, G., Sippl, W. and Jung, M. (2007) Target-based approach to inhibitors of histone arginine methyltransferases. Journal of Medicinal Chemistry, 50, 2319-2325.
55. Le Romancer, M., Treilleux, I., Leconte, N., Robin-Lespinasse, Y., Sentis, S., Bouchekioua-Bouzaghou, K., Goddard, S., Gobert-Gosse, S. and Corbo, L. (2008) Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Molecular Cell, 31, 212-221.
56. Majumder, S., Liu, Y., Ford, O.H. 3rd, Mohler, J.L. and Whang, Y.E. (2006) Involvement of arginine methyltrans-ferase CARM1 in androgen receptor function and prostate cancer cell viability. Prostate, 66, 1292-1301.
57. Meyer, R., Wolf, S.S. and Obendorf, M. (2007) PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor. The Journal of Steroid Biochemistry and Molecular Biology, 107, 1-14.
58. Cheung, N., Chan, L.C., Thompson, A., Cleary, M.L. and Eric So, C.W. (2007) Protein arginine-methyltransferase-dependent oncogenesis. Nature Cell Biology, 9, 1208-1215.
59. Pawlak, M.R., Scherer, C.A., Chen, J., Roshon, M.J. and Ruley, H.E. (2000) Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Molecular and Cellular Biology, 20, 4859-4869.
60. Pal, S., Vishwanath, S.N., Erdjument-Bromage, H., Tempst, P. and Sif, S. (2004) Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Molecular and Cellular Biology, 24, 9630-9645.
61. Chen, X., Niroomand, F., Liu, Z., Zankl, A., Katus, H.A., Jahn, L. and Tiefenbacher, C. P. (2006) Expression of nitric oxide related enzymes in coronary heart disease. Basic Research in Cardiology, 101, 346-353.
62. Dacwag, C.S., Ohkawa, Y., Pal, S., Sif, S. and Imbalzano, A.N. (2007) The protein arginine methyltransferase Prmt5 is required for myogenesis because it facilitates ATP-dependent chromatin remodeling. Molecularand Cellular Biology, 27, 384-394.
63. Hess, J.L. (2004) Mechanisms of transformation by MLL. Critical Reviews in Eukaryotic Gene Expression, 14, 235-254.
64. Cooper, C.S., Campbell, C. and Jhavar, S. (2007) Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer. Nature Clinical Practices in Urology, 4, 677-687.
65. Kang, M.Y., Lee, B.B., Kim, Y.H., Chang, D. K., Kyu Park, S., Chun, H.K., Song, S.Y., Park, J. and Kim, D.H. (2007) Association of the SUV39H1 histone methyltrans-ferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer. International Journal of Cancer, 121, 2192-2197.
66. Kondo, Y., Shen, L., Ahmed, S., Boumber, Y., Sekido, Y., Haddad, B.R. and Issa, J.P. (2008) Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS ONE, 3, e2037.
67. Marango, J., Shimoyama, M., Nishio, H., Meyer, J.A., Min, D.J., Sirulnik, A., Martinez-Martinez, Y., Chesi, M., Bergsagel, P.L., Zhou, M.M., Waxman, S., Leibovitch, B.A., Walsh, M.J. and Licht, J.D. (2008) The MMSETprotein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood, 111, 3145-3154.
68. Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V.M., Su, L., Xu, G. and Zhang, Y. (2005) hDOT1L links histone methylation to leukemogenesis. Cell, 121, 167-178.
69. Kuendgen, A. and Lubbert, M. (2008) Current status of epigenetic treatment in myelodysplastic syndromes. Annals of Hematology (in press).
70. Liao, J.J. (2007) Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. Journal of Medicinal Chemistry, 50, 409-424.
71. Vedel, M., Lawrence, F., Robert-Gero, M. and Lederer, E. (1978) The antifungal antibiotic sinefungin as a very active inhibitor of methyltransferases and of the transformation of chick embryo fibroblasts by Rous sarcoma virus. Biochemical and Biophysical Research Communications, 85, 371-376.
72. McGovern, S.L., Caselli, E., Grigorieff, N. and Shoichet, B.K. (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. Journal ofMedicinal Chemistry, 45, 1712-1722.
73. Ragno, R., Simeoni, S., Castellano, S., Vicidomini, C., Mai, A., Caroli, A., Tramontano, A., Bonaccini, C., Trojer, P., Bauer, I., Brosch, G. and Sbardella, G. (2007) Small molecule inhibitors of histone arginine methyltransferases: homology modeling, molecular docking, binding mode analysis, and biological evaluations. Journal ofMedicinal Chemistry, 50, 1241-1253.
74. Mai, A., Cheng, D., Bedford, M.T., Valente, S., Nebbioso, A., Perrone, A., Brosch, G., Sbardella, G., De Bellis, F., Miceli, M. and Altucci, L. (2008) Epigenetic multiple ligands: Mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors. Journal ofMedicinal Chemistry, 51, 2279-2290.
75. Balasubramanyam, K., Varier, R.A., Altaf, M., Swaminathan, V., Siddappa, N.B., Ranga, U. and Kundu, T.K. (2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. The Journal of Biological Chemistry, 279, 51163-51171.
76. Trapp, J., Jochum, A., Meier, R., Saunders, L., Marshall, B., Kunick, C., Verdin, E., Goekjian, P.G., Sippl, W. and Jung, M. (2006) Adenosine mimetics as inhibitors of NAD +-dependent histone deacetylases, from kinase to sirtuin inhibition. Journal ofMedicinal Chemistry, 49, 7307-7316.
77. Purandare, A.V., Chen, Z., Huynh, T., Pang, S., Geng, J., Vaccaro, W., Poss, M.A., Oconnell, J., Nowak, K. and Jayaraman, L. (2008) Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1). Bioorganic & Medicinal Chemistry Letters, 18, 4438-4441.
78. Spannhoff, A., Machmur, R., Heinke, R., Trojer, P., Bauer, I., Brosch, G., Schule, R., Hanefeld, W., Sippl, W. and Jung, M. (2007) A novel arginine methyltrans-ferase inhibitor with cellular activity. Bioorganic & Medicinal Chemistry Letters, 17, 4150-4153.
79. Heinke, R., Spannhoff, A., Meier, R., Trojer, P., Bauer, I., Jung, M. and Sippl, W., (2008) Virtual Screening and Biological Characterisation of Novel Histone Arginine Methyltransferase PRMT1 Inhibitors. 3 (in press).
80. Osborne, T., Roska, R.L., Rajski, S.R. and Thompson, P.R. (2008) In Situ Generation of a Bisubstrate Analogue for Protein Arginine Methyltransferase 1. Journal of the American Chemical Society (in press).
81. Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E. and Imhof, A. (2005) Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nature Chemical Biology, 1, 143-145.
82. Kubicek, S., O'Sullivan, R.J., August, E.M., Hickey, E.R., Zhang, Q., Teodoro, M.L., Rea, S., Mechtler, K., Kowalski, J.A., Homon, C.A., Kelly, T.A. and Jenuwein, T. (2007) Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Molecular Cell, 25, 473-481.
83. Frietze, S., Lupien, M., Silver, P.A. and Brown, M. (2008) CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Research, 68, 301-306.
84. Hong, H., Kao, C., Jeng, M.H., Eble, J.N., Koch, M.O., Gardner, T.A., Zhang, S., Li, L., Pan, C.X., Hu, Z., MacLennan, G.T. and Cheng, L. (2004) Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status. Cancer, 101, 83-89.
85. Lee, Y.H., Coonrod, S.A., Kraus, W.L., Jelinek, M.A. and Stallcup, M.R. (2005) Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. Proceedings ofthe National Academy of Sciences ofthe United States ofAmerica, 102, 3611-3616.
86. Le Guezennec, X., Vermeulen, M., Brinkman, A.B., Hoeijmakers, W.A., Cohen, A., Lasonder, E. and Stunnenberg, H.G. (2006) MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Molecular and Cellular Biology, 26, 843-851.
87. Verbiest, V., Montaudon, D., Tautu, M.T., Moukarzel, J., Portail, J.P., Markovits, J., Robert, J., Ichas, F. and Pourquier, P. (2008) Protein arginine (N)-methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins. FEBS Letters, 582, 1483-1489.
88. Pogribny, I.P., Tryndyak, V.P., Muskhelishvili, L., Rusyn, I. and Ross, S.A. (2007) Methyl deficiency, alterations in global histone modifications, and carcinogenesis. The Journal ofNutrition, 137, 216S-222.
89. McGarvey, K.M., Fahrner, J.A., Greene, E., Martens, J., Jenuwein, T. and Baylin, S.B. (2006) Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Research, 66, 3541-3549.
90. Aniello, F., Colella, G., Muscariello, G., Lanza, A., Ferrara, D., Branno, M. and Minucci, S. (2006) Expression of four histone lysine-methyltransferases in parotid gland tumors. Anticancer Research, 26, 2063-2067.
91. Li, H., Rauch, T., Chen, Z.X., Szabo, P.E., Riggs, A.D. and Pfeifer, G.P. (2006) The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. The Journal ofBiological Chemistry, 281, 19489-19500.
92. Saigo, K., Yoshida, K., Ikeda, R., Sakamoto, Y., Murakami, Y., Urashima, T., Asano, T., Kenmochi, T. and Inoue, I. (2008) Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. Human Mutation, 29, 703-708.
93. Hamamoto, R., Silva, F.P., Tsuge, M., Nishidate, T., Katagiri, T., Nakamura, Y. and Furukawa, Y. (2006) Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Science, 97, 113-118.
94. Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Silva, F.P., Li, M., Yagyu, R. and Nakamura, Y. (2004) SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nature Cell Biology, 6, 731-740.
95. Scoumanne,A.and Chen,X. (2008) Protein methylation: a new mechanism of p53 tumor suppressor regulation. Histology and Histopathology, 23, 1143-1149.